These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16283214)

  • 1. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
    Lye DC; Hughes A; O'Brien D; Athan E
    Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):753-5. PubMed ID: 16283214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
    Prabhu RM; Orenstein R
    Clin Infect Dis; 2004 Oct; 39(8):1253-4. PubMed ID: 15486856
    [No Abstract]   [Full Text] [Related]  

  • 3. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
    Rajendram R; Alp NJ; Mitchell AR; Bowler IC; Forfar JC
    Clin Infect Dis; 2005 May; 40(9):e72-4. PubMed ID: 15825018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
    Jiménez-Expósito MJ; Torres G; Baraldés A; Benito N; Marco F; Paré JC; Moreno A; Claramonte X; Mestres CA; Almela M; García de la María C; Pérez N; Schell WA; Corey GR; Perfect J; Jiménez de Anta MT; Gatell JM; Miró JM
    Clin Infect Dis; 2004 Oct; 39(7):e70-3. PubMed ID: 15472836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
    Roel JE; Gamba A; Curone M; Pescio A; Bruno C; Finquelievich J
    Medicina (B Aires); 1998; 58(3):301-2. PubMed ID: 9713102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
    Lejko-Zupanc T; Kozelj M
    J Infect; 1997 Jul; 35(1):81-2. PubMed ID: 9279731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
    del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
    Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
    Agnelli C; Guinea J; Valerio M; Escribano P; Bouza E; Muñoz P
    Rev Esp Quimioter; 2019 Aug; 32(4):395-397. PubMed ID: 31327188
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.
    Nishida T; Mayumi H; Kawachi Y; Tokunaga S; Maruyama Y; Nakashima A; Yasui H; Tokunaga K
    Surg Today; 1994; 24(7):651-4. PubMed ID: 7949778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
    Piñar D; Reus S; Pérez P; Quiles JA
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):66-7. PubMed ID: 19419799
    [No Abstract]   [Full Text] [Related]  

  • 11. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.
    Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J
    J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida glabrata endophthalmitis treated successfully with caspofungin.
    Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
    Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocarditis caused by Candida dubliniensis.
    Garcia J; Soch K; Matthew E; Surani S; Horseman MA
    Am J Med Sci; 2013 Sep; 346(3):237-9. PubMed ID: 23974269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspofungin as treatment for Candida glabrata hip infection.
    Lejko-Zupanc T; Mozina E; Vrevc F
    Int J Antimicrob Agents; 2005 Mar; 25(3):273-4. PubMed ID: 15737527
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis.
    Aaron L; Therby A; Viard JP; Lahoulou R; Dupont B
    Scand J Infect Dis; 2003; 35(5):351-2. PubMed ID: 12875529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin: a new therapeutic option for fungal endocarditis.
    Nevado J; De Alarcón A; Hernández A
    Clin Microbiol Infect; 2005 Mar; 11(3):248. PubMed ID: 15715728
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
    López-Ciudad V; Castro-Orjales MJ; León C; Sanz-Rodríguez C; de la Torre-Fernández MJ; Pérez de Juan-Romero MA; Collell-Llach MD; Díaz-López MD
    BMC Infect Dis; 2006 Apr; 6():73. PubMed ID: 16608509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
    Jones JM; Sarsam MA; Clarke MA; Hedderwick SA
    J Infect; 2002 Apr; 44(3):196-8. PubMed ID: 12099751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.